Latest Sustainability News

American Tungsten & Antimony Ltd has inked an underwriting deal with GBA Capital to ensure full subscription of up to 69 million AT4N options expiring this month, securing potential capital injection amid its US critical minerals push.

JPMorgan Asset Management has released updated estimated annual cash distributions for six of its ASX-listed ETFs for the financial year ending 30 June 2026, with amounts varying widely between funds and one yielding no distribution.

Resouro Strategic Metals has unveiled a robust Preliminary Economic Assessment for its Tiros Titanium and Rare Earths Project, signalling a post-tax NPV of US$715 million and a 44.2% IRR over 20 years. Meanwhile, binding agreements for mining and processing at the Novo Mundo Gold Project promise to unlock additional value.

Burger Fuel Group posted a 92% surge in net profit to NZ$1.97 million for FY26, driven by steady system sales growth, a one-off store sale gain, and reduced legal expenses, while geopolitical instability in the Middle East weighs on international sales.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.

Cann Group Limited has agreed to fully redeem its outstanding convertible notes with Obsidian Global GP, LLC at 100% of face value, foregoing the usual early redemption premium. This move concludes the convertible securities facility established earlier in the year.

Euro Manganese has filed comprehensive NI 43-101 and JORC reports for its Chvaletice Manganese Project, confirming robust economics with a base case post-tax NPV of US$492 million and an upside scenario pushing NPV to US$798 million, driven by higher manganese prices.

Latrobe Magnesium has reached a third of construction completion at its Phase 1B Demonstration Plant, maintaining strong safety standards and progressing key installation milestones. The company targets first magnesium metal output in the second half of 2026, aligning with prior guidance.

Saluda Medical has obtained FDA approval for its CAP24 surgical paddle lead, a first-of-its-kind device designed for closed-loop spinal cord stimulation, poised to broaden its US market reach and engage new surgical specialties.

Truscreen Group has issued nearly 150 million new shares at NZ$0.013 each, expanding its share base by 17.4% following a renounceable rights issue. The fully paid shares rank equally with existing stock, lifting total ordinary shares to just over one billion.

Almonty Industries has been added to the Russell 1000 and 3000 indexes, marking a key milestone in its market capitalization growth and enhancing its visibility among institutional investors.